Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 19, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Epilepsy
Interventions
DRUG

Mangafodipir

Patients will be imaged interictally with a gadolinium enhanced MRI session. The administration of mangafodipir will be done as an inpatient during long-term video EEG recording, to ensure administration in the peri-ictal period.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH